Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Systemic Coadministration of Chloramphenicol with Intravenous but not Intracerebroventricular Morphine Markedly Increases Morphine Antinociception and Delays Development of Antinociceptive Tolerance in Rats

Maree T. Smith, Carsten K. Nielsen, Megan Y. C. Lim-Fraser, Andrew W. E. Wright and Michael Lau
Drug Metabolism and Disposition February 2000, 28 (2) 236-244;
Maree T. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten K. Nielsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan Y. C. Lim-Fraser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew W. E. Wright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Chloramphenicol, an in vitro inhibitor of the glucuronidation of morphine to its putative antianalgesic metabolite, morphine-3-glucuronide (M3G), was coadministered with morphine in adult male Sprague-Dawley rats to determine whether it inhibited the in vivo metabolism of morphine to M3G, thereby enhancing morphine antinociception and/or delaying the development of antinociceptive tolerance. Parenteral chloramphenicol was given acutely (3-h studies) or chronically (48-h studies). Morphine was administered by the i.v. or i.c.v. route. Control rats received chloramphenicol and/or vehicle. Antinociception was quantified using the hotplate latency test. Coadministration of chloramphenicol with i.v. but not i.cv. morphine increased the extent and duration of morphine antinociception by ≈5.5-fold relative to rats that received i.v. morphine alone. Thus, the mechanism through which chloramphenicol enhances i.v. morphine antinociception in the rat does not directly involve supraspinal opioid receptors. Acutely, parenteral coadministration of chloramphenicol and morphine resulted in an ≈75% increase in the mean area under the serum morphine concentration-time curve but for chronic dosing there was no significant change in this curve, indicating that factors other than morphine concentrations contribute significantly to antinociception. Antinociceptive tolerance to morphine developed more slowly in rats coadministered chloramphenicol, consistent with our proposal that in vivo inhibition of M3G formation would result in increased antinociception and delayed development of tolerance. However, our data also indicate that chloramphenicol inhibited the biliary secretion of M3G. Whether chloramphenicol altered the passage of M3G and morphine across the blood-brain barrier remains to be investigated.

Footnotes

  • Send reprint requests to: Maree T. Smith, School of Pharmacy, The University of Queensland, St. Lucia, Brisbane, Queensland, 4072, Australia. E-mail: maree.smith{at}pharmacy.uq.edu.au

  • ↵1 Parts of this research were presented in Abstract form at the National Scientific Conferences of ASCEPT (Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists) and APSA (Australasian Pharmaceutical Sciences Association) in 1994 and 1996, respectively.

  • M.Y.C.L.-F. was supported in part by a scholarship funded by AIDAB (Australian International Development Assistance Bureau). A.W.E.W. and this research were supported financially by the Queensland Cancer Fund. M.L. was supported in part by a Vacation Scholarship funded by Pharmaceutical Defense Limited. This research was also supported financially by The University of Queensland Research Grants Scheme.

  • Abbreviations used are::
    SD
    Sprague-Dawley
    AUC
    area under the serum morphine and M3G concentration-time curve
    CNS
    central nervous system
    M3G
    morphine-3-glucuronide
    M6G
    morphine-6-glucuronide
    %MPE
    percentage of maximum possible antinociceptive effect
    %MPE AUC
    area under the %MPE versus time curve (extent and duration of antinociception)
    • Received May 20, 1999.
    • Accepted September 29, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (2)
Drug Metabolism and Disposition
Vol. 28, Issue 2
1 Feb 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Systemic Coadministration of Chloramphenicol with Intravenous but not Intracerebroventricular Morphine Markedly Increases Morphine Antinociception and Delays Development of Antinociceptive Tolerance in Rats
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Systemic Coadministration of Chloramphenicol with Intravenous but not Intracerebroventricular Morphine Markedly Increases Morphine Antinociception and Delays Development of Antinociceptive Tolerance in Rats

Maree T. Smith, Carsten K. Nielsen, Megan Y. C. Lim-Fraser, Andrew W. E. Wright and Michael Lau
Drug Metabolism and Disposition February 1, 2000, 28 (2) 236-244;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Systemic Coadministration of Chloramphenicol with Intravenous but not Intracerebroventricular Morphine Markedly Increases Morphine Antinociception and Delays Development of Antinociceptive Tolerance in Rats

Maree T. Smith, Carsten K. Nielsen, Megan Y. C. Lim-Fraser, Andrew W. E. Wright and Michael Lau
Drug Metabolism and Disposition February 1, 2000, 28 (2) 236-244;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics